The FTSE Show 43 | Astrazeneca plc [AZN]

£85 for a share in AZN.

New deals for them on the cards. Lots of investors with low horizons getting excited about grabbing some quick profits. None of which are guarenteed.

But what about the long term? What are the odds the share price can rise another 100% and hit £160 in the next 10 years? Unlikely? That’s only 10% a year.

So is this company a good long term buy? Or is it best to invest capital elsewhere?

I cover the answers to all these questions in this weeks episode of The FTSE Show, which I’ve literally just uploaded.

Opt In Image
Get My Weekly Stock Investing Newsletter

Allow me to catapult you years ahead of the game by sharing what you can't learn from books

My readers are learning how to improve their investment returns, avoid costly mistakes and know exactly which stocks to buy and which to avoid. Sign up for my non-spammy, useful as hell newsletter. I never share your details and I only ever email you if I have something incredibly useful to say. No fluff. No wasting your time. If you hate what I post, you can unsubscribe. But my unsubscribe rate is very low for a reason. This is one of the best FREE sources of my content.

Please note, some mail providers throw my emails in the junk folders because they may not recognise me as a contact of yours. Please check in there if it hasn't arrived.

About Chris Chillingworth

An ex-fraud investigator who is now a self-trained stock market analyst. Chris found his passion in analysing FTSE stocks for his own investment portfolio and now provides his analysis to others via his exclusive investment club.

View all posts by Chris Chillingworth

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.